The company has been pressing the FDA to hold a formal hearing on its proposed jet lag label expansion for Hetlioz since it was first snubbed way back in 2019.
A sweeping new study reveals that what’s on your plate may directly shape the pesticides circulating in your body. Researchers found that people who eat more fruits and vegetables known to carry higher pesticide residues—such as strawberries, spinach, and bell peppers—also have significantly higher levels of those chemicals in their urine. While produce remains a cornerstone of a healthy diet, the
Researchers at Kobe University have developed an AI system that can detect acromegaly, a rare hormone disorder, by analyzing photos of the back of the hand and a clenched fist. The disease often develops slowly and can take years to diagnose, even though untreated cases may shorten life expectancy.
The primary growth drivers in Bayer’s pharma sector—Nubeqa and Kerendia—are performing even better than the company anticipated and their momentum is expected to continue in 2026. But that won’t lead to growth of Bayer’s pharma business overall this year as two contraction drivers—Xarelto and Eylea—are working in the opposite direction.
Not long after Novo Nordisk received an untitled letter from the FDA disputing certain elements of the first TV spot for its Wegovy pill, another of the Danish drugmaker’s GLP-1 ads is in the regulator’s crosshairs.
Moderna will pay $950 million upfront—and no future royalties—to settle patent litigation over its mRNA-based vaccine Spikevax. The case was brought by Roivant subsidiary Genevant and infectious disease biotech Arbutus back in 2022.
When we are ill, we need expertise more than ever, yet our agency feels fragile. The best clinicians recognize this, a patient writes.
UnitedHealth used to disclose more than 3,100 subsidiaries. Its latest annual reports shows just 10.
NoA Health has appointed Louisa Lee as CEO, putting the former Novo Nordisk and Pfizer employee at the head of the creative agency’s push to take its business global.
Sanofi is betting $1.53 billion on a novel drug from Sino Biopharmaceutical, securing global rights to a first-in-class JAK/ROCK inhibitor that could play a double role in the French pharma’s hematology and immunology pipeline.
A settlement provides a massive windfall for Arbutus and Roivant and avoids a worst-case scenario for Moderna.
A new study has uncovered why some brain cells are more resistant to Alzheimer’s damage than others. Researchers found a natural cleanup system that helps remove toxic tau protein before it can form harmful clumps. The study also shows that cellular stress can produce a dangerous tau fragment linked to Alzheimer’s. Strengthening the brain’s natural defenses could point the way to new treatments.
As states try to contain the cost of prescription drugs, Virginia lawmakers are pushing an affordability board they believe will go further than efforts in other states.
A group of autism researchers and advocates are forming an independent advisory body to develop a scientific agenda for the autism community.
Trump is trying to shift the focus toward healthy eating and cheaper drugs. But vaccines keeping coming back up.
Pfizer CEO Albert Bourla, Ph.D., has weighed in with sharp criticism of the FDA’s Vinay Prasad, M.D., and his performance as the chief of the Center for Biologics Evaluation and Research, which regulates vaccines in the U.S.
In a Q&A for Fierce Pharma Marketing’s “Rising Stars” series, Kraemer discussed how patients inspire his work, his advice for industry veterans and how he unwinds on the fairway.
Scientists have uncovered a surprising new hero in the fight against one of the world’s deadliest fungal infections: albumin, the most abundant protein in human blood. In a major international study, researchers found that people who develop mucormycosis — a fast-moving and often fatal “black fungus” infection — have strikingly low levels of albumin, and that this deficiency strongly predicts deat
When a bone break is too severe to heal on its own, surgeons often rely on grafts or rigid metal implants — but both come with serious drawbacks. Now, researchers at ETH Zurich have created a jelly-like hydrogel that mimics the body’s natural healing process, offering a potentially game-changing alternative. Made of 97% water, this soft material can be laser-printed into intricate bone-like struct
Dr. McDreamy has signed onto yet another cancer awareness initiative. “Grey’s Anatomy” star Patrick Dempsey, who has worked with Amgen since 2007 and joined forces with Pfizer in 2024, is now collaborating with cancer test maker Guardant Health.